Moderna’s mRNA RSV vaccine delivers impressive Phase 3 trial results
For decades researchers have been trying to develop a vaccine for the deadly respiratory disease. It looks like 2023 will be the landmark year where not only one, but possibly three different vaccines are approved.
Moderna’s mRNA RSV vaccine delivers impressive Phase 3 trial results Read more